<DOC>
	<DOC>NCT01012648</DOC>
	<brief_summary>RCT colloids versus cristalloids only in severe burn victims. - Trial with medicinal product</brief_summary>
	<brief_title>Early Fluid Resuscitation With Balanced HES 130/0.4 [6%] in Severe Burn Injury</brief_title>
	<detailed_description />
	<criteria>Inclusion criteria: Deep burn injury more than 15% of total body surface area (2nd and 3rd degree burns) Informed consent (via deferred consent, if necessary, according to Swiss HMG § 55 and 56). Patients or relatives can understand the study information and the provided information in German language Exclusion criteria: Patients expected to succumb within the next 24 to 36 hours, i.e. whole body burn trauma, palliative care situation Pregnancy No informed consent Known allergic reaction to HES Patients or patient's relatives, who do not understand the German language and therefore the study information, can not be provided in a legally correct manner. Patients with contraindications for balanced 6% HES 130/0.4, i.e. heart failure, pulmonary edema, intracerebral bleeding, acute renal failure, severe hypernatraemia and other severe electrolyte imbalances, severe vonWillebrand Syndrome and acute liver failure (see "Arzneimittelkompendium der Schweiz® Documed")</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>